iBio (IBIO) Non Operating Income (2010 - 2026)
iBio's Non Operating Income came in at $779,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $35,000 a year earlier and up 22.7% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Non Operating Income (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Non Operating Income was $2.1 million, up 832.0% from FY2025.
- Non Operating Income carries a five-year compound annual growth rate of -23.3% (FY2021 to FY2026).
- Going back by fiscal year, Non Operating Income was $225,000 in FY2025 (-81.1%), $1.19 million in FY2024, $32,000 in FY2023 (-82.6%) and $184,000 in FY2022 (-97.7%).
- The fiscal Q4 2026 figure represents the highest quarterly Non Operating Income since fiscal Q3 2024.
- Year-over-year, Non Operating Income increased in four of the last six quarters, with growth averaging 255.6%.
- The fastest year-over-year change in Non Operating Income over five years came in fiscal Q2 2026 (growth of 721.8%), and the weakest in fiscal Q4 2022 (a decline of 99.3%).
- Business Quant data shows IBIO's Non Operating Income at $635,000 (Q3 2026), $452,000 (Q2 2026) and $231,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | 787,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 787,000.00 |
| Jun 30, 2026 | 779,000.00 |
| Mar 31, 2026 | 635,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 991,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | -110,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 40,000.00 |
API Access
iBio Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();